BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38719503)

  • 1. Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial.
    Chang AB; Yerkovich ST; Baines KJ; Burr L; Champion A; Chatfield MD; Eg KP; Goyal V; Marsh RL; McCallum GB; McElrea M; McPhail S; Morgan LC; Morris PS; Nathan AM; O'Farrell H; Sanchez MO; Parsons M; Schultz A; Torzillo PJ; West NP; Versteegh L; Marchant JM; Grimwood K
    BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38719503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing exacerbations in children and adults with primary ciliary dyskinesia using erdosteine and/or azithromycin therapy (REPEAT trial): study protocol for a multicentre, double-blind, double-dummy, 2×2 partial factorial, randomised controlled trial.
    Chang AB; Morgan LC; Duncan EL; Chatfield MD; Schultz A; Leo PJ; McCallum GB; McInerney-Leo AM; McPhail SM; Zhao Y; Kruljac C; Smith-Vaughan HC; Morris PS; Marchant JM; Yerkovich ST; Cook AL; Wurzel D; Versteegh L; O'Farrell H; McElrea MS; Fletcher S; D'Antoine H; Stroil-Salama E; Robinson PJ; Grimwood K
    BMJ Open Respir Res; 2022 May; 9(1):. PubMed ID: 35534039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial.
    Chang AB; Grimwood K; Robertson CF; Wilson AC; van Asperen PP; O'Grady KA; Sloots TP; Torzillo PJ; Bailey EJ; McCallum GB; Masters IB; Byrnes CA; Chatfield MD; Buntain HM; Mackay IM; Morris PS
    Trials; 2012 Aug; 13():156. PubMed ID: 22937736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of a personalised
    Marchant JM; Chang AB; Schutz KL; Versteegh L; Cook A; Roberts J; Morris PS; Yerkovich ST; McCallum GB
    BMJ Open; 2021 Dec; 11(12):e049007. PubMed ID: 34937712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
    Valery PC; Morris PS; Byrnes CA; Grimwood K; Torzillo PJ; Bauert PA; Masters IB; Diaz A; McCallum GB; Mobberley C; Tjhung I; Hare KM; Ware RS; Chang AB
    Lancet Respir Med; 2013 Oct; 1(8):610-620. PubMed ID: 24461664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation.
    Calverley PM; Page C; Dal Negro RW; Fontana G; Cazzola M; Cicero AF; Pozzi E; Wedzicha JA
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2733-2744. PubMed ID: 31819405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchiectasis - Exercise as Therapy (BREATH): rationale and study protocol for a multi-center randomized controlled trial.
    Jones T; O'Grady KF; Goyal V; Masters IB; McCallum G; Drovandi C; Lung T; Baque E; Brookes DSK; Terranova CO; Chang AB; Trost SG
    Trials; 2022 Apr; 23(1):292. PubMed ID: 35410363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial.
    Goyal V; Grimwood K; Byrnes CA; Morris PS; Masters IB; Ware RS; McCallum GB; Binks MJ; Marchant JM; van Asperen P; O'Grady KF; Champion A; Buntain HM; Petsky H; Torzillo PJ; Chang AB
    Lancet; 2018 Oct; 392(10154):1197-1206. PubMed ID: 30241722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial.
    Goyal V; Grimwood K; Ware RS; Byrnes CA; Morris PS; Masters IB; McCallum GB; Binks MJ; Smith-Vaughan H; O'Grady KF; Champion A; Buntain HM; Schultz A; Chatfield M; Torzillo PJ; Chang AB
    Lancet Respir Med; 2019 Sep; 7(9):791-801. PubMed ID: 31427252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial.
    Chang AB; Grimwood K; Wilson AC; van Asperen PP; Byrnes CA; O'Grady KA; Sloots TP; Robertson CF; Torzillo PJ; McCallum GB; Masters IB; Buntain HM; Mackay IM; Ungerer J; Tuppin J; Morris PS
    Trials; 2013 Feb; 14():53. PubMed ID: 23421781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial.
    Valery PC; Morris PS; Grimwood K; Torzillo PJ; Byrnes CA; Masters IB; Bauert PA; McCallum GB; Mobberly C; Chang AB
    BMC Pediatr; 2012 Aug; 12():122. PubMed ID: 22891748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOspitalised Pneumonia Extended (HOPE) Study to reduce the long-term effects of childhood pneumonia: protocol for a multicentre, double-blind, parallel, superiority randomised controlled trial.
    Chang AB; Fong SM; Yeo TW; Ware RS; McCallum GB; Nathan AM; Ooi MH; de Bruyne J; Byrnes CA; Lee B; Nachiappan N; Saari N; Torzillo P; Smith-Vaughan H; Morris PS; Upham JW; Grimwood K
    BMJ Open; 2019 Apr; 9(4):e026411. PubMed ID: 31023759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide antibiotics for bronchiectasis.
    Kelly C; Chalmers JD; Crossingham I; Relph N; Felix LM; Evans DJ; Milan SJ; Spencer S
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012406. PubMed ID: 29543980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial.
    O'Grady KA; Grimwood K; Cripps A; Mulholland EK; Morris P; Torzillo PJ; Wood N; Smith-Vaughan H; Revell A; Wilson A; Van Asperen P; Richmond P; Thornton R; Rablin S; Chang AB
    Trials; 2013 Sep; 14():282. PubMed ID: 24010917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial.
    Dal Negro RW; Visconti M; Turco P
    Pulm Pharmacol Ther; 2015 Aug; 33():47-51. PubMed ID: 26116425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study.
    Dal Negro RW; Wedzicha JA; Iversen M; Fontana G; Page C; Cicero AF; Pozzi E; Calverley PMA; ;
    Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29025888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis.
    Morton M; Wilson N; Homer TM; Simms L; Steel A; Maier R; Wason J; Ternent L; Abouhajar A; Allen M; Joyce R; Hildreth V; Lakey R; Cherlin S; Walker A; Devereux G; Chalmers JD; Hill AT; Haworth C; Hurst JR; De Soyza A
    BMJ Open; 2023 Aug; 13(8):e071906. PubMed ID: 37562935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for bronchiectasis: an overview of Cochrane systematic reviews.
    Welsh EJ; Evans DJ; Fowler SJ; Spencer S
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010337. PubMed ID: 26171905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study).
    Marchioni CF; Polu JM; Taytard A; Hanard T; Noseda G; Mancini C
    Int J Clin Pharmacol Ther; 1995 Nov; 33(11):612-8. PubMed ID: 8688986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.